Panic attack nasal spray trial pulled before it began
NCT ID NCT07162649
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to test a nasal spray containing dexmedetomidine for quickly relieving panic attacks in adults. Panic attacks affect about 13% of adults, and current fast-acting treatments can be addictive. The spray was designed to work within minutes. However, the trial was withdrawn before enrolling any participants, so no results are available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- dexmedetomidine nasal spray
- What this could lead to
- If it had worked, this could have pointed toward a fast-acting, non-addictive treatment for panic attacks.
- What could go wrong
- The trial was withdrawn before any participants were enrolled, so no data on safety or effectiveness were collected. It is unknown if the spray would have worked or caused side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEXMEDETOMIDINE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a Two-Drug anesthesia combo lift Post-Surgery mood?
- Can a simple infusion make sinus surgery safer and clearer?
- Drug combo may cut opioid use after lung surgery
- Which Add-On drug eases pain after gallbladder surgery? a Head-to-Head test
- Nighttime drug cocktail aims to help seniors sleep better after joint surgery
- Can a simple additive make eye surgery safer for the heart?